Order Article Reprints

Kinami T, Amioka K, Kawaoka T, Uchikawa S, Yamasaki S, Kosaka M, Johira Y, Yano S, Naruto K, Ando Y, et al. Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein. Cancers. 2023; 15(8):2304. https://doi.org/10.3390/cancers15082304

Kinami, Takahiro, Kei Amioka, Tomokazu Kawaoka, Shinsuke Uchikawa, Shintaro Yamasaki, Masanari Kosaka, Yusuke Johira, Shigeki Yano, Kensuke Naruto, Yuwa Ando, and et al. 2023. "Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein" Cancers 15, no. 8: 2304. https://doi.org/10.3390/cancers15082304

Kinami, T., Amioka, K., Kawaoka, T., Uchikawa, S., Yamasaki, S., Kosaka, M., Johira, Y., Yano, S., Naruto, K., Ando, Y., Yamaoka, K., Fujii, Y., Fujino, H., Nakahara, T., Ono, A., Murakami, E., Okamoto, W., Yamauchi, M., Miki, D., ... Oka, S. (2023). Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein. Cancers, 15(8), 2304. https://doi.org/10.3390/cancers15082304